Sanguine Media Ltd

Key financial results and board actions

• Board approved unaudited quarterly results for quarter ended 30 June 2026 with Limited Review Report.
• Revenue from operations (unaudited) 0.00 for the quarter ended 30 June 2026.
• Total income 1.66 for the quarter ended 30 June 2026.
• Profit after tax for the quarter ended 30 June 2026: 0.06.
• Audit Committee reviewed results; Board approved the outcomes.
• No separate segment information disclosed due to single primary business segment.

Other disclosures

• Reviewed the company’s other businesses as part of the board’s discussions.

Meeting Details

• Date: 11 August 2026; Time not disclosed; Location: Registered Office, Sanguine Media Limited.

Key Agenda Items

• Unaudited quarterly results for the quarter ended 30 June 2026, with Auditor's Limited Review Report.

Other Notes

• Trading window closure periods are not specified.

Dematerialisation/rematerialisation status

• Dematerialisation requests processed during the quarter; accepted/rejected and listed on exchanges.
• Physical certificates for dematerialisation mutilated and cancelled after verification; depository registered owner substitution completed within prescribed timelines.
• Securities dematerialised/rematerialised listed on the stock exchanges.

Sanguine Media Ltd closes trading window from July 01, 2026 till 48 hours after the declaration of its Unaudited Financial Results for the Quarter ended June 30, 2026

Independent Directors Meeting

• Reviewed performance of non-independent directors and entire board
• Assessed chairperson's performance with input from executive and non-executive directors
• Evaluated quality and timeliness of information flow between management and board

Meeting Details ️

• Independent Directors' meeting scheduled for 20 March 2026 at the registered office.

Key Agenda Items

• Review performance of Non-Independent Directors and the entire board.
• Assess the Chairman's performance.
• Evaluate quantity, quality, and timeliness of information flow.

Financial Performance

• Q3 FY26 revenue from operations was ₹0.00 lac, down from ₹5.10 lac in Q3 FY25.
• Q3 FY26 total income was ₹2.10 lac, down from ₹5.10 lac in Q3 FY25.
• Nine months ended Dec 31, 2025, revenue from operations was ₹0.00 lac versus ₹10.00 lac prior year.
• Nine months total income was ₹8.13 lac in FY26 versus ₹10.00 lac in FY25.
• Q3 FY26 profit before tax was ₹0.04 lac, compared to a loss of ₹5.40 lac in Q3 FY25.
• Nine months FY26 PBT was a profit of ₹0.29 lac versus a loss of ₹13.08 lac prior year.

Expenses & Other Financials

• Employee benefits expense decreased to ₹0.85 lac in Q3 FY26 from ₹1.30 lac in Q3 FY25.
• Other expenses were ₹1.21 lac in Q3 FY26, down from ₹1.70 lac in Q3 FY25.
• No finance costs or depreciation reported in Q3 FY26; finance cost was ₹0 in Q3 FY25.
• No tax expense reported for any period.
• Earnings per share (basic and diluted) for Q3 FY26 was ₹0.00, compared to (₹0.00) in Q3 FY25.

Corporate Actions & Reporting

• Board approved Q3 and nine months unaudited financial results and limited review report on Feb 11, 2026.
• Results prepared under Indian Accounting Standards; previous period figures regrouped.
• No exceptional or discontinued operations reported.

Business Model & Segments

• Sanguine Media Limited operates in the media sector; no segment-wise revenue disclosed.

Financial Performance

• Board approved unaudited financial results for Q3 and nine months ended December 31, 2025.
• Total income for nine months ended December 31, 2025 was Rs. 8.13 lakhs (unaudited).
• Profit before tax for nine months ended December 31, 2025 was Rs. 0.29 lakhs (unaudited).
• Profit after tax for nine months ended December 31, 2025 was Rs. 0.29 lakhs (unaudited).
• Earnings per share for nine months ended December 31, 2025 was Rs. 0.00 basic and diluted.
• No exceptional items or tax expenses reported for the period.

Capital Structure

• Paid-up equity share capital remained Rs. 11,410 lakhs with face value Rs. 10 per share.

Audit ️

• Statutory auditors issued a limited review report on the unaudited financial results.